<DOC>
	<DOCNO>NCT01624324</DOCNO>
	<brief_summary>The aim study determine whether plasma concentration aminoglycoside Indonesia neonates infection within safe effective range association cochlear toxicity nephrotoxicity .</brief_summary>
	<brief_title>Aminoglycoside Plasma Level Measurement Neonates With Infection</brief_title>
	<detailed_description>Aminoglycosides toxic antibiotic , urgently need treat newborn severe infection . Aminoglycosides well know nephrotoxicity ototoxicity , meanwhile renal function newborn yet fully developed.The aminoglycoside dosage currently apply Indonesia derive study do Caucasian population . The safety efficacy dosage regimen , however , never evaluate till date . The pharmacokinetic profile drug may vary population may influence genetic factor , lifestyle , drug interaction , etc . The detection aminoglycoside toxicity newborn usually problematic . The present study aim know proportion nephrotoxicity ototoxicity newborns Cipto Mangunkusumo Hospital treat gentamicin amikacin relation trough serum concentration . The serum level gentamicin amikacin assume safe trough serum concentration &lt; 2 mcg/mL effective 5-12 mcg/mL . For amikacin desire trough serum concentration &lt; 10 mcg/mL peak 20-30 mcg/mL . The nephrotoxicity assess measure level kidney injury molecule-1 urine ototoxicity assess Distortion Product Otoacoustic Emission ( DPOE ) instrument .</detailed_description>
	<criteria>neonate infection treat gentamicin amikacin neonate hypersensitive gentamicin amikacin neonate also treat nephrotoxic drug ( vancomycin , furosemide , amphotericin B , meropenem )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>aminoglycoside</keyword>
	<keyword>KIM-1</keyword>
	<keyword>DPOAE</keyword>
	<keyword>nephrotoxicity</keyword>
	<keyword>ototoxicity</keyword>
</DOC>